Possible involvement of endogenous 5-HT in aggravation of cerulein-induced acute pancreatitis in mice

Journal of Pharmacological Sciences

Volumn 105, Issue 3, 2007, Pages 240-250

  Hamada, Kentaro ^a   Yoshida, Masanori ^b,c   Isayama, Hiroyuki ^d   Yagi, Yoshiki ^a   Kanazashi, Shuichi ^a   Kashihara, Yasunari ^a   Takeuchi, Koji ^e   Yamaguchi, Isamu ^a  

^a UMN Pharma Inc   (Japan)

^b OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c OSAKA BIOSCIENCE INSTITUTE   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

^e KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

5 HT2A receptor activation; Cerulein induced acute pancreatitis; Histological alteration; Hyperenzymemia; Serotonin (5 HT)

Indexed keywords

1 [5 (2 THIENYLMETHOXY) 3 INDOLYL] 2 PROPANAMINE; 6 CHLORO 5 METHYL 1 [[2 [(2 METHYL 3 PYRIDYL)OXY] 5 PYRIDYL]CARBAMOYL]INDOLINE; CERULETIDE; GLEMANSERIN; KETANSERIN; METERGOLINE; METHYSERGIDE; RISPERIDONE; RITANSERIN; SEROTONIN; SEROTONIN 2A AGONIST; SEROTONIN 2C AGONIST; SEROTONIN AGONIST; SPIPERONE;

ACUTE PANCREATITIS; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CELL INFILTRATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; DRUG POTENCY; FEMALE; HISTOPATHOLOGY; INFLAMMATORY CELL; MOUSE; NONHUMAN; ORGAN WEIGHT; RECEPTOR BINDING;

EID: 36348974165     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.FP0071049     Document Type: Article

References (43)

1. Bülbring E, Crema A. The release of 5-hydroxytryptamine in relation to pressure exerted on the intestinal mucosa. J Physiol. 1959;146:18-28.
2. Andrews PL, Rapeport WG, Sanger GJ. Neuropharmacology of emesis induced by anti-cancer therapy. Trends Pharmacol Sci. 1988;9:334-341.
3. Andrews PL, Davison JS. Activation of vagal afferent terminals by 5-HT is mediated by 5-HT3 receptors in the anaesthetized ferret. J Physiol. 1990;422:9P.
4. Li Y, Owyang C. Vagal afferent pathways mediate physiological action of cholecystokinin on pancreatic secretion. J Clin Invest. 1993;92:418-424.
5. Li Y, Hao Y, Zhu JX, Owyang C. Serotonin released from intestinal enterochromaffin cells mediates luminal non-CCK stimulated pancreatic secretion in rats. Gastroenterology. 2000;118:1197-1207.
6. Zhu JX, Wu XY, Owyang C, Li Y. Intestinal serotonin acts as a paracrine substance to mediate signal transmission evoked by luminal factors in the rat. J Physiol. 2001;530:431-442.
7. Owyang C, Logsdon CD. New insights into neurohormonal regulation of pancreatic secretion. Gastroenterology. 2004;127:957-969.
8. Steer ML, Meldolesi J. The cell biology of experimental pancreatitis. New Engl J Med. 1987;316:144-150.
9. Lampel M, Kern HF. Acute interstitial pancreatitis in the rat induced by excessive doses of a pancreatic secretagogue. Virchows Arch (Pathol Anat). 1977;373:97-117.
10. Saluja AK, Saluja M, Printz H, Zavertnik A, Sengupta A, Steer ML. Experimental pancreatitis is mediated by low-affinity cholecystokinin receptors that inhibit digestive enzyme secretion. Proc Natl Acad Sci U S A. 1989;86:8968-8971.
11. Niederau C, Ferrel LD, Grendell JH. Caerulein-induced acute necrotizing pancreatitis in mice: Protective effects of proglumide, benzotript and secretin. Gastroenterology. 1985;88:1192-1204.
12. Sakate K, Kimura K, Saito T. Therapeutic effects of loxiglumide on experimental acute pancreatitis using various models. Digestion. 1999;60:64-68.
13. 2-serotonergic receptor antagonist, ketanserin, on cerulein-induced pancreatitis in the rat. Life Sci. 1992;50:733-737.
14. 2 receptor activation in aggravation of diet-induced acute pancreatitis in mice. J Pharmacol Exp Ther. 1997;283:1495-1502.
15. 2A receptors in the development of experimental pancreatitis. Eur J Pharmacol. 2005;521:156-163.
16. 2C receptors. Br J Pharmacol. 1995;115:622-628.
17. 2A receptor antagonist R-102444. Eur J Pharmacol. 2002;457:107-114.
18. 2C receptors. Naunyn Schmiedebergs Arch Pharmacol. 2004;370:114-123.
19. Wiley J, Owyang C. Participation of serotonin and substance P in the action of cholecystokinin on colonic motility. Am J Physiol. 1987;252:G431-G435.
20. Stallone D, Nicolaidis S, Gibbs J. Cholecystokinin-induced anorexia depends on serotoninergic function. Am J Physiol. 1989;256:R1138-R1141.
21. Celiński K, Kleinrok Z, Pokora J, Czechowska G, Skrzydło-Radomańska B, Cichoż-Lach H. The effect of caerulein-induced acute pancreatitis on the levels of serotonin (5-HT) and 5-hydroxyindoleacetic acid (5-HIAA) in various rat tissues. J Physiol Pharmacol. 1995;46:163-167.
22. Prinz RA, Fareed J, Rock A, Squillaci G, Wallenga J. Platelet activation by human pancreatic fluid. J Surg Res. 1984;37:314-319.
23. Stern L, Tenenhouse A, Yu EW. Uptake, storage and secretion of 5-hydroxytryptamine and its amino acid precursor by dispersed rat pancreas acinar cells. J Physiol. 1983;340:555-567.
24. Falardeau P, Heisler S. 5-Hydroxytryptamine synthesis, storage, and secretion from rat pancreatic acinar cells. Can J Physiol. 1984;62:755-761.
25. Roth BL, Craigo SC, Choudhary MS, Uluer A, Monsma FJ Jr, Shen Y, et al. Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors. J Pharmacol Exp Ther. 1994;268:1403-1410.
26. Hoyer D, Clarke DE, Fozard JR, Hartig PR, Martin GR, Mylecharane EJ, et al. International union of pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol Rev. 1994;46:157-203.
27. Morcillo EJ, Cortijo J. Species differences in the responses of pulmonary vascular preparation to 5-hydroxytryptamine. Therapie. 1999;54:93-97.
28. Centurion D, Ortiz MI, Sanchez-Lopez A, De Vries P, Saxena PR, Villalon CM. Evidence for 5-HT(1B/1D) and 5-HT(2A) receptors mediating constriction of the canine internal carotid circulation. Br J Pharmacol. 2001;132:983-990.
29. Calama E, Fernandez MM, Moran A, Martin ML, San Roman L. Vasodilator and vasoconstrictor responses induced by 5-hydroxytryptamine in the in situ blood autoperfused hindquarters of the anaesthetized rat. Naunyn Schmiedebergs Arch Pharmacol. 2002;366:110-116.
30. 1C-like receptors. Naunyn Schmiedebergs Arch Pharmacol. 1993;347:471-477.
31. Bodelson M, Tornebrandt K, Arneklo-Nobin B. Endothelial relaxing 5-hydroxytryptamine receptors in the rat jugular vein: similarity with the 5-hydroxytryptamine 1C receptor. J Pharmacol Exp Ther. 1993;264:709-716.
32. Klar E, Rattner DW, Compton C, Stanford G, Chernow B, Warshaw AL. Adverse effect of therapeutic vasoconstrictors in experimental pancreatitis. Ann Surg. 1991;214:168-174.
33. Kyogoku T, Manabe T, Tobe T. Role of ischemia in acute pancreatitis. Hemorrhagic shock converts edematous pancreatitis to hemorrhagic pancreatitis in rats. Dig Dis Sci. 1992;37:1409-1417.
34. 2B receptors of endothelium-dependent relaxation in rat jugular vein. Br J Pharmacol. 1995;114:400-404.
35. Glusa E, Roos A. Endothelial 5-HT receptors mediate relaxation of porcine pulmonary arteries in response to ergotamine and dihydroergotamine. Br J Pharmacol. 1996;119:330-334.
36. Glusa E, Pertz HH. Further evidence that 5-HT-induced relaxation of pig pulmonary artery is mediated by endothelial 5-HT (2B) receptors. Br J Pharmacol. 2000;130:692-698.
37. Bhatia M, Saluja AK, Hofbauer B, Lee HS, Frossard JL, Steer ML. The effects of neutrophil depletion on a completely noninvasive model of acute pancreatitis-associated lung injury. Int J Pancreatol. 1998;24:77-83.
38. Inoue S, Nakao A, Kishimoto W, Murakami H, Itoh K, Itoh T, et al. Anti-neutrophil antibody attenuates the severity of acute lung injury in rats with experimental acute pancreatitis. Arch Surg. 1995;130:93-98.
39. Han SL, Abe Y, Miyauchi K, Watanabe Y, Sato N, Kimura S. Therapeutic efficacy of antineutrophil monoclonal antibody, Urge-8, against acute necrotizing pancreatitis in rats. Surgery. 1996;119:585-591.
40. Fujie E, Irie K, Uchida Y, Tsukahara F, Muraki T. Possible role of nitric oxide in 5-hydroxytryptamine-induced increase in vascular permeability in mouse skin. Naunyn Schmiedebergs Arch Pharmacol. 1994;350:361-364.
41. Charles A, Rounds S, Farber HW. Neutrophil chemoattractant production by cultured serotonin-stimulated bovine and human endothelial cells. Am J Physiol. 1991;261:L133-L139.
42. Ito T, Ikeda U, Shimpo M, Yamamoto K, Shimada K. Serotonin increases interleukin-6 synthesis in human vascular smooth muscle cells. Circulation. 2000;102:2522-2527.
43. Kubera M, Maes M, Kenis G, Kim YK, Lason W. Effects of serotonin and serotonergic agonists and antagonists on the production of tumor necrosis factor alpha and interleukin-6. Psychiatry Res. 2005;134:251-258.